SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-036727
Filing Date
2024-04-26
Accepted
2024-04-26 17:15:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 ea0204619-s1a1_virpax.htm S-1/A 505258
2 CONSENT OF EISNERAMPER LLP ea0204619ex23-1_virpax.htm EX-23.1 3631
3 GRAPHIC image_001.jpg GRAPHIC 4282
4 GRAPHIC image_002.jpg GRAPHIC 129724
5 GRAPHIC image_003.jpg GRAPHIC 110735
  Complete submission text file 0001213900-24-036727.txt   847481
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278796 | Film No.: 24885269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)